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Abstract
Bub1 is a serine/threonine kinase originally described as a core component of the spindle 
assembly checkpoint (SAC) mechanism in yeast. Bub1 binding at kinetochores has been reported 
to be required for SAC function and localization of other SAC components. A proper SAC is 
believed to be essential for murine embryonic development, as all previously described null 
mutations in SAC components in mice cause embryonic lethality. We produced mice harboring a 
Bub1 mutant allele lacking exons 2 and 3, resulting in a hypomorphic mutant expressed at <5% of 
wild-type levels. Despite this significant reduction, homozygous mutant animals are viable on a 
mixed 129P2/B6 or FVB background but display increased tumorigenesis with aging, whereas 
mice with a C57Bl/6J background die perinatally. Bub1 mutant murine embryonic fibroblasts 
(MEFs) display defects in chromosome congression to the metaphase plate, severe chromosome 
missegregation, and aneuploidy accompanied by high levels of premature senescence. Mutant 
MEFs have a robust SAC in response to nocodazole treatment but an impaired response to Taxol. 
Mutant MEFs also show reduced kinetochore localization of BubR1, but not of Mad2. The 
significant reduction in SAC response to Taxol, but not nocodazole, coupled with the reduced 
binding of BubR1, but not Mad2, indicates that Bub1 is particularly critical for the SAC response 
to a lack of tension on kinetochores. Thus, Bub1 is essential for proper chromosome segregation, a 
defect that can lead to severe phenotypes, including perinatal lethality and a predisposition to 
cancer.
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Proper chromosome segregation is critical at every cell division to prevent aneuploidy, a 
condition associated with aggressive cancer, birth defects, and infertility (reviewed in ref. 1). 
The spindle assembly checkpoint (SAC) is a major guardian of mitotic fidelity. The SAC 
works as a checkpoint and timing mechanism to delay sister chromatid separation and 
anaphase onset until all chromosomes achieve bipolar attachment to microtubules at the 
metaphase plate. The SAC can be activated by lack of kinetochore-microtubule attachment 
or loss of tension on the kinetochore microtubules, thus allowing it to respond to the major 
types of aneuploidy-generating defects that arise during mitotic progression (reviewed in 
refs. 1–3). The SAC blocks anaphase entry by inhibiting the APC/Cdc20 complex, a 
multisubunit ubiquitin ligase that induces anaphase by promoting proteosomal degradation 
of mitotic substrates. The mechanism of APC/Cdc20 inhibition by the SAC is multitiered, 
including inhibitory binding of SAC components Mad2 and/or BubR1 to Cdc20 and Bub1-
mediated inhibitory phosphorylation of APC/Cdc20 (3). Distinct inhibitory pathways may 
be activated by different conditions (e.g., loss of microtubule attachment versus loss of 
tension), although it remains unclear whether the different regulatory mechanisms function 
in separate pathways or as part of an integrated signaling system. The relative contributions 
of each mechanism to overall mitotic fidelity are also not well understood.
The spindle checkpoint machinery is encoded by a core group of genes originally identified 
in Saccharomyces cerevisiae, including Mad1–3, Bub1, Bub3, and Mps1. Yeasts lacking 
core SAC components grow normally under unperturbed conditions yet display increased 
rates of chromosome missegregation and are unable to grow in the presence of spindle 
poisons, such as nocodazole (4–6). Studies of SAC function in mammals have been limited 
by the fact that murine null mutations in core SAC components, including Bub3, Mad1, 
Mad2, and BubR1, cause very early embryonic lethality, precluding analysis of embryonic 
fibroblasts or later developmental stages in null mutants (7–10). However, mouse embryonic 
fibroblasts (MEF) heterozygous for Mad2, Bub3, and BubR1 displayed haploinsufficiency, 
resulting in higher levels of mitotic abnormalities (9, 11, 12). Furthermore, whereas 
heterozygous animals were viable in each case, they displayed increased age-related 
spontaneous (11) or carcinogen-induced (9, 13) tumorigenesis. Mice with a hypomorphic 
BubR1 allele that reduced BubR1 levels to ∼11% of wild type (wt) were viable but 
displayed cellular senescence, growth retardation, and progeroid features without a 
significant increase in tumor formation (12). These studies indicate that the SAC is essential 
for early embryonic development in mammals but that the phenotypes obtained from 
incomplete SAC impairment may vary across a broad range, depending on the depleted 
component and the degree of depletion. SAC components may also have SAC-independent 
functions that contribute to the observed phenotypes in some cases (14–16).
Despite its identification as a core spindle checkpoint component in yeasts, the functions of 
Bub1 have not been fully elucidated. Bub1 is a serine/threonine kinase that localizes to 
kinetochores during mitosis and mediates efficient kinetochore localization of other SAC 
components. Bub1 deletion in yeasts causes high chromosome missegregation rates under 
normal growth conditions, in addition to lethality under perturbed conditions (4–6). Studies 
in vertebrate systems have been confined to biochemical and cell culture models and have 
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produced some conflicting results about Bub1 roles in mitotic regulation. Bub1 is essential 
for spindle checkpoint activity in Xenopus extracts, and the bulk of this activity requires the 
NH2 terminus, with minor requirements for the COOH terminal kinase functions (17, 18). In 
cultured mammalian cell lines, Bub1 reduction via RNA interference (RNAi) produced 
conflicting results. In one case, Bub1 was surprisingly dispensable for the SAC function but 
was required for chromosome congression (15). An independent study found that Bub1 was 
required for a functional SAC response to nocodazole while confirming the role in 
chromosome congression (16). These differences are difficult to reconcile but may stem 
from distinct levels of Bub1 depletion and/or differences in cell lines used for the studies. 
More recent studies have revealed a role for Bub1 in meiotic and mitotic sister chromatid 
cohesion via interaction with shugoshin (19, 20). Finally, compromised Bub1 function has 
been indirectly associated with tumorigenesis, indicating an important need to understand 
the molecular links associated with Bub1 function, mitotic regulation, and tumor 
suppression (21–24).
To better understand Bub1 functions and the consequences of Bub1 loss in vivo, we 
developed a conditional Bub1 mutation in mice. We report here that this mutation is 
hypomorphic, causing a severe reduction in Bub1 levels. Mice homozygous for the Bub1 
hypomorph mutation are viable on mixed 129P2/B6 and FVB genetic backgrounds but 
display high rates of tumorigenesis. The mutant phenotype is more severe on a C57Bl/6J 
background, where homozygous mutants die perinatally. In MEFs, Bub1 mutation causes 
high rates of chromosome missegregation and aneuploidy, accompanied by growth defects 
and premature senescence. Surprisingly, the spindle checkpoint is functional in Bub1 mutant 
MEFs, although the checkpoint response to Taxol is significantly impaired. BubR1 
kinetochore localization is markedly reduced in Bub1 mutant MEFs, consistent with the 
conclusion that Bub1 plays a key role in a BubR1-dependent tension-sensitive SAC 
response. These findings indicate that Bub1 is critical for proper progression through mitosis 
and that defects in Bub1 signaling cause severe defects ranging from early lethality to 
tumorigenesis.
Materials and Methods
Bub1 gene targeting and mice
Bub1 genomic BAC clones were isolated from a 129SvEv library by hybridization screening 
and subsequent PCR verification. The bacterial strain EL350 (25) was used for 
“recombineering” to subclone a 13-kb fragment encompassing Bub1 exons 1 to 6 into a 
pUC19-based plasmid, including a phosphoglycerate kinase–thymidine kinase gene (a gift 
of R. Thresher, University of North Carolina Animal Models Core Facility). A loxP site was 
inserted in intron 1 by recombineering a loxP-flanked zeocin cassette, followed by Cre-
mediated cassette removal in EL350. A loxP and FRT-flanked neomycin resistance cassette 
was subsequently inserted into intron 3. The targeting vector was linearized and used for 
gene targeting in E14 ES cells (129P2/OlaHsd strain). ES cell targeting was verified by PCR 
and Southern blot, and correctly targeted clones were injected into C57Bl/6J blastocysts for 
chimera generation. Chimeric males were bred to C57Bl/6J females, and germline 
transmission of the Bub1neo allele was verified by PCR. The BubΔ2-3 and Bub1f alleles were 
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generated by crossing the Bub1neo allele with an X-linked CMV-Cre strain (26). BubΔ2-3 
viability phenotypes were studied on three genetic backgrounds: 129/B6 (F2-F4), B6N4+, 
and FVBN7+. For the FVB studies, the Bub1Δ2-3 allele was independently derived from the 
Bub1neo allele by crossing (FVBN5)Bub1neo/+ animals to an FVB-β-actin-Cre deleter strain. 
The Cre transgene was removed by segregation before intercrossing BubΔ2-3/+ animals. 
MEF studies were performed with MEFs derived from embryos on the C57Bl/6J 
background (B6N4+). All mice were maintained according to the Institutional Animal Care 
and Use Committee at the University of North Carolina at Chapel Hill.
Bub1GT8 allele
Bub1 gene-trapped ES cell clone XG453 was obtained from Bay Genomics. The gene trap is 
produced by a splice-acceptor-β-geo cassette within Bub1 intron 7. XG453 ES cells were 
injected into C57Bl/6J blastocysts, and resulting chimeras were bred to C57Bl/6J females 
and screened for germline transmission by PCR. Animals used in experiments reported here 
were backcrossed one to two generations to C57Bl/6J. All animal experiments were 
approved by the Institutional Animal Care and Use Committee of the University of North 
Carolina at Chapel Hill.
Cell culture
MEF lines were generated from e13.5-e14.5 using standard protocols. MEFs were cultured 
at 5% CO2 in media containing DMEM-H with 10% fetal bovine serum, 2 mmol/L 
glutamine, 50 μg/mL penicillin, 50 μg/mL streptomycin, and 55 μmol/L 2-mercaptoethanol 
and were passaged every 2 d by plating 500,000 viable cells. All experiments with MEFs 
were performed at passages 3 to 4, unless otherwise stated. Growth curves were generated 
by counting total number of viable cells at each passage. Drug treatments were used at the 
following concentrations: nocodazole (Sigma-Aldrich), 200 ng/mL; paclitaxel (Sigma-
Aldrich), 1 μmol/L; MG132 (Calbiochem), 10 μmol/L.
Spindle checkpoint analysis
Asynchronously growing MEFs were treated with 200 ng/mL nocodazole for indicated 
times, trypsinized, fixed for 20 min in 1% formaldehyde, spun down, and resuspended in 
70% cold ethanol. For flow cytometry, cells were stained with anti–phosphorylated histone 
H3 (Upstate Biotechnology) at 1:500 and Alexafluor 488 (Invitrogen) at 1:1,000, followed 
by propidium iodide. Cells (30,000) were analyzed on a Becton Dickinson FACScan, and 
the number of phosphorylated histone H3– postive cells was measured as a percentage of 
total cells.
Immunofluorescence
Coverslips were fixed in 2% formaldehyde, permeablized in PBS + 0.5% Triton X-100 
(PBS-TX), and washed in PBS. After blocking for 30 min in PBS-TX plus 5% nonfat dried 
milk (NFDM) or bovine serum albumin (BSA), coverslips were incubated overnight with 
primary antibodies. Antibodies were used at the following concentrations: rabbit anti–
phosphorylated histone H3,1:500 (Upstate Biotechnology); anti–β-tubulin, 1:250 (Tub2.1, 
Sigma-Aldrich); sheep anti-Bub1, 1:500 (Steve Taylor); rabbit anti-Mad2, 1:500 (E.D. 
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Salmon); rabbit anti-BubR1, 1:500 (BD Biosciences); human anti-centromere, 1:500 (ACA, 
Antibodies Incorporated.). After washes with PBS-TX, coverslips were incubated for 1 h 
with appropriate secondary antibodies (Alexafluor 488 or 594) at 1:500 in PBS-TX plus 5% 
NFDM or BSA, washed with PBS-TX, stained with 4′,6-diamidino-2-phenylindole (DAPI), 
and mounted with Flouromount G (Electron Microscopy Sciences). Analysis was carried out 
on a Leica DMRXA microscope. See supplementary data for specifics on kinetochore 
localization methods.
Karyotyping
MEFs at passage 5 were treated with Karyomax colcemid (Invitrogen) for 4 h, trypsinized, 
resuspended in warm 75 mmol/L hypotonic KCl buffer, and incubated for 20 min. Cells 
were washed at least four times in Carnoy's buffer before being resuspended in fresh 
Carnoy's fix, dropped into cold, ethanol-washed slides, and stained with DAPI. Images of 
single-cell spreads were acquired on a Leica DMRXA microscope with a 63 × objective. 
Chromosomes from distinct individual cells were counted, with chromosome numbers of 
>70 for a sinsgle cell being discarded as endoreduplication.
Senescence assay
MEFs grown on coverslips at indicated passages were fixed in 1% formaldeyde and 0.1% 
glutaraldehyde for 5 min before being treated overnight (14–18 h) in senescence-associated 
β-galactosidase assay buffer (see ref. 27). Cells were counterstained with DAPI, and cells, 
staining positive for senescence, were counted as a percentage of total cells.
Western blotting and immunoprecipitation
Subconfluent MEFs were treated with 200 ng/mL nocodazole for 6 h, lysed in modified 
radioimmunoprecipitation assay buffer, separated by SDS-PAGE, and transferred to 
nitrocellulose membranes. Membranes were blocked for 30 to 60 min in PBS + 0.1% Tween 
20 (PBS-T) with 5% NFDM, incubated overnight at 4°C with anti-Bub1 at 1:1,000 (a kind 
gift from Steve Taylor), and diluted in PBS-T + 5% NFDM. For immunoprecipitation, plates 
of subconfluent cells were treated with 200 ng/mL of nocodazole for 6 h and 10 μm of 
MG132 for 2 h. Cells were collected from plates as above. Total protein (500 μg) was 
incubated overnight at 4°C with 50 μL anti-Bub1 sera (28).
Results
Generation of the Bub1Δ2-3 allele
We generated a conditional mutation of the murine Bub1 gene by homologous 
recombination in ES cells. Based on available sequence information, deletion of exons 2 and 
3 was predicted to cause a null allele by creating a frameshift early in exon 4, leading to a 
premature stop codon in exon 6 (Fig. 1A). The targeting construct was designed with a loxP 
site in intron 1 and a loxP-flanked neomycin resistance cassette in intron 3, thus allowing 
deletion of exons 2 and 3 by Cre-mediated recombination (Supplementary Fig. S1A). 
Correctly targeted ES cell clones were used to generate chimeric founders that transmitted 
the Bub1neo allele through the germline (Supplementary Fig. S1B). Bub1neo/+ mice were 
crossed to a germline Cre deleter strain (see Materials and Methods) to produce the Bub1 
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floxed allele (Bub1f) by removal of the neomycin resistance cassette and the Bub1Δ2-3 allele 
by removal of the neo cassette and exons 2 and 3. Bub1neo/+, Bub1f/+, and Bub1Δ2-3/+ mice 
are viable and fertile. Genotypes were confirmed by PCR (Supplementary Fig. S1C).
Bub1Δ2-3/Δ2-3 survival is dependent on genetic background
Homozygous deletion of spindle checkpoint genes Mad2, Bub3, and BubR1 in mice causes 
embryonic lethality at e4.5-7.5 during rapid expansion of the inner cell mass (7, 8, 10). 
Bub1Δ2-3/+ mice were intercrossed to test whether Bub1 loss also causes early embryonic 
lethality. Surprisingly, Bub1Δ2-3/Δ2-3 animals were obtained at near Mendelian ratios from 
intercrosses on a mixed 129P2/B6 genetic background (Table 1). However, intercrosses 
performed after backcrossing four or more generations to C57Bl/6J yielded live 
Bub1Δ2-3/Δ2-3 animals at only 20% of expected Mendelian frequency (Table 1), and nearly 
all live-born (B6)Bub1Δ2-3/Δ2-3 mice died perinatally. (B6)Bub1Δ2-3/Δ2-3 mice seemed to 
breathe and nurse normally but displayed runting and failure to thrive in the early postnatal 
period. The average weight of Bub1Δ2-3/Δ2-3 animals was 1.19 ± 0.06 g versus 1.41 ± 0.13 g 
for wt (P < 0.01) on day of birth. To date, only two homozygous animals survived to 
weaning at 21 days. To determine when the remaining 80% of (B6)Bub1Δ2-3/Δ2-3 mice die, 
embryos were generated from (B6)Bub1Δ2-3/+ intercrosses at E13.5-14.5 and E17.5-18.5. At 
both E13.5-14.5 and E17.5-18.5, (B6)Bub1Δ2-3/Δ2-3, (B6)Bub1Δ2-3/+, and (B6)Bub1+/+ 
embryos were recovered at Mendelian ratios (Table 1). Histologic analysis of sections from 
e14.5 and e18.5 whole embryos did not reveal any morphologic defects (data not shown). 
Observations of cell death in the liver and the marked paleness of some (B6)Bub1Δ2-3/Δ2-3 
embryos led us to perform cell blood count analysis on blood from e18.5 embryos, revealing 
mild anemia and leukocytosis. In summary, (B6)Bub1Δ2-3/Δ2-3 mice displayed perinatal 
lethality of unknown cause, whereas Bub1Δ2-3/Δ2-3 animals were viable on a 129/B6 mixed 
background. We also derived the Bub1∆2-3 allele on an FVB genetic background, in which 
(FVB)Bub1Δ2-3/Δ2-3 animals are obtained at Mendelian ratios (Table 1). Together, these 
results indicate that that the phenotype of the Bub1Δ2-3 allele is modified by the genetic 
background. The perinatal lethal phenotype of (B6)Bub1Δ2-3/Δ2-3 animals is similar to that of 
mice harboring a hypomorphic mutation of the BubR1 spindle checkpoint gene (12), as well 
as mice with mutations of DNA damage genes, such as BRCA2 (29). This observation, 
coupled with results from inactivation of other spindle checkpoint genes in mice, strongly 
suggests that the Bub1Δ2-3 allele retains partial function.
The Bub1Δ2-3 allele is hypomorphic
The recovery of viable Bub1Δ2-3/Δ2-3 mice suggested the Bub1Δ2-3 allele may be 
hypomorphic rather than null. To test this hypothesis, we obtained mice harboring a Bub1 
gene-trap allele with a β-geo cassette and splice acceptor inserted in intron 7 (see Materials 
and Methods). Intercrosses of Bub1gt8/+ animals revealed a likely maternal defect in 
breeding, as very few live mice of any genotype were recovered from these crosses and 90% 
of embryos were resorbed by e14.5. Crosses of Bub1Δ2-3/+ females with Bub1gt8/+ males 
showed that compound heterozygous (Bub1Δ2-3/gt8) animals were absent before e11.5 (Table 
1). Because the genetic background in these experiments is mixed 129/B6 (a background 
that supported survival of Bub1Δ2-3/Δ2-3 animals), the failure to recover compound 
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heterozygous animals at midgestation is strong genetic evidence that the BubΔ2-3 allele is 
hypomorphic, as the Bub1gt8 allele is apparently more severe.
To determine the nature of the Bub1Δ2-3 mutation, we first analyzed mRNA production in 
MEFs from E14.5 embryos. Quantitative reverse transcription–PCR (RT-PCR; not shown) 
and Northern hybridization analysis showed equivalent RNA levels in Bub1+/+ and 
Bub1Δ2-3/Δ2-3 MEFs (Supplementary Fig. S2A). Bub1Δ2-3/Δ2-3 MEFs expressed a single 
Bub1 mRNA that was smaller than the wt mRNA, consistent with the deletion of exons 2 
and 3. cDNA from Bub1Δ2-3/Δ2-3 MEFs was cloned and sequenced, demonstrating that the 
mRNA produced from the mutant allele is spliced from exon 1 to exon 4, as predicted 
(Supplementary Fig. S2B). No novel alternatively spliced RNAs were detected by Northern 
or RT-PCR analyses using various primer sets across the Bub1 mRNA sequence (data not 
shown). Together, these data suggest that the residual function of the Bub1Δ2-3 allele, if any, 
must be derived from the Δ2-3 mutant mRNA.
Analysis of the predicted mRNA from the Bub1Δ2-3 allele suggested two alternative 
possibilities for mutant protein expression: (a) an ATG codon 5′ to the published start codon 
could produce a protein that is out of frame until reaching the exon 1 to exon 4 splice but in-
frame thereafter (aa77–aa1058) and/or (b) translation from in-frame internal ATGs present 
in exon 4 or beyond producing NH2 terminal truncations (aa103 or aa173–aa1058; Fig. 1A). 
These ATGs are not in Kozak consensus sequences but could still give rise to protein (30). 
To distinguish these possibilities, we analyzed protein from Bub1Δ2-3/Δ2-3 MEFs by Western 
blot using an antibody raised against Bub1 aa336-aa489 (31). No Bub1 protein was detected 
in extracts from Bub1Δ2-3/Δ2-3 MEFs, whereas Bub1Δ2-3/+ and Bub1+/+ MEFs expressed a 
Bub1 protein of expected size (Fig. 1B). Likewise, no protein was detected in 129/Bl6 
Bub1Δ2-3/Δ2-3 MEFs or tissues (data not shown). Titration of wt cell lysate showed the 
sensitivity of Bub1 detection to be 5% of normal endogenous levels (Fig. 1C), indicating 
that the Bub1Δ2-3 allele disrupts production of the wt Bub1 protein and that any protein 
produced from the mutant allele must be produced at <5% of wt levels. 
Immunoprecipitation–Western blot analysis using an antibody recognizing residues 1-331 of 
the Bub1 protein for immunoprecipitation (28) and the antibody recognizing residues 
336-489 for Western blot analysis (31) detected a mutant-specific band of ∼115 kDa in 
Bub1∆Δ2-3/Δ2-3 and Bub1Δ2-3/+ samples (Fig. 1D). This protein could be produced by 
translation from either an upstream or downstream ATG and, thus, lacks at least the NH2 
terminal 73 aa of Bub1. Thus, the phenotypes observed in Bub1Δ2-3/Δ2-3 mice and MEFs 
could be due to the lack of a critical NH2 terminal Bub1 domain, severely diminished 
protein levels, or both.
Bub1 and BubR1 kinetochore localization are reduced in Bub1Δ2-3/Δ2-3 MEFs
Bub1 localizes to kinetochores in response to lack of spindle attachment and/or tension and 
is required for efficient localization of other spindle checkpoint proteins that mediate the 
spindle checkpoint activity (15). The domain required for Bub1 kinetochore localization is 
encoded by exon 8 and is, thus, likely to be included in the protein encoded by the Bub1Δ2-3 
allele (32). Nevertheless, Bub1 staining at kinetochores of Bub1Δ2-3/Δ2-3 MEFs was only 2% 
of wt (Fig. 2A), consistent with severely reduced total levels of mutant Bub1 protein.
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In cultured cell lines, Bub1 is required for efficient kinetochore localization of other spindle 
checkpoint proteins, such as Mad2 and BubR1 in response to SAC activation (15, 33). SAC 
activation can be modeled experimentally by treating cells with nocodazole (which causes a 
loss of kinetochore-spindle attachment and tension) or Taxol (which disrupts tension forces 
between kinetochores while leaving attachments intact). Using immunofluorescence, we 
examined the Mad2 and BubR1 at kinetochores of Bub1Δ2-3/Δ2-3 MEFs after nocodazole or 
Taxol treatment. However, significant cell-to-cell variation and high background with ACA 
staining precluded accurate measurement (Supplementary Fig. S3). To control for the 
variance, cells singly stained with Mad2 or BubR1 were counted and classified according to 
level of kinetochore localization (Fig. 2B): ++++, bright kinetochore staining; +++, dim 
above background kinetochore staining; ++, kinetochore staining at punctate background 
levels; +, no kinetochore staining. Using this stratification, a clear difference in kinetochore 
localization of BubR1, but not Mad2, was detected in response to both nocodazole and 
Taxol. Mad2 staining was clearly evident at kinetochores (++++ or +++) in 100% of 
Bub1+/+ and 93% of Bub1Δ2-3/Δ2-3 MEFs after nocodazole treatment. Mad2 localization 
after Taxol treatment is comparably weak in both wt and mutant cells (Fig. 2C). In contrast, 
BubR1 kinetochore localization was greatly reduced in Bub1Δ2-3/Δ2-3 cells when treated with 
nocodazole (44% of cells had clear kinetochore localization versus 99% of wt; P < 0.05) or 
Taxol (15% versus 83%, respectively, P < 0.05; Fig. 2D). These results indicate that Bub1 is 
necessary for proper BubR1 kinetochore localization in response to lack of kinetochore-
microtubule attachment and, particularly, to the lack of microtubule tension.
Bub1Δ2-3/Δ2-3 MEFs exhibit a defective spindle checkpoint, chromosome segregation 
errors, and increased aneuploidy
Kinetochore localization of SAC proteins Mad2 and BubR1 has previously been speculated 
to be necessary for SAC function. The reduced BubR1 kinetochore localization in 
Bub1Δ2-3/Δ2-3 MEFs suggested that these cells may have a defective SAC response. We 
tested spindle checkpoint responses of Bub1Δ2-3/Δ2-3, Bub1∆2-3/+, and wt MEFs by 
measuring mitotic indices (percentage of positive phosphorylated histone H3) after 
treatment with nocodazole or Taxol. Bub1+/+, Bub1Δ2-3/+, and Bub1Δ2-3/Δ2-3 MEFs all 
showed an increased mitotic index by 12 hours after nocodazole addition compared with 
untreated cultures, indicating that each genotype retains at least partial SAC function in 
response to spindle ablation (Fig. 3A). Nocodazole-treated Bub1Δ2-3/+ and Bub1Δ2-3/Δ2-3 
cultures contained only modestly lower indices (5.8% and 7%, respectively) than the 
Bub1+/+ cultures (8.9%). This result contrasts with reported results from MEFs 
heterozygous for a null mutation in Bub3 or a hypomorphic mutation of BubR1, which show 
a severely impaired arrest in response to nocodazole treatment (9, 12). Likewise, there was 
no increase in premature sister chromatid separation after treatment with colcemid (2.5% in 
Bub1Δ2-3/Δ2-3 versus 1.5% in Bub1+/+), another microtubule depolymerizing agent. In 
contrast to nocodazole treatment, Bub1Δ2-3/Δ2-3 MEFs did display a severe SAC defect in 
response to Taxol treatment (mitotic index, 3.5% for Bub1Δ2-3/Δ2-3 versus 8% for Bub1+/+; 
Fig. 3A). These data suggest that reduced protein levels and/or NH2 terminal deletion of 
Bub1 is more detrimental to the response to the loss of tension than the loss of attachment.
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The primary role of the spindle checkpoint is to aid proper segregation of the chromosomes 
by delaying anaphase until all chromosomes are attached and under tension by spindle 
fibers. Loss of the spindle checkpoint has been linked to increased aneuploidy in several 
models of spindle checkpoint loss (9, 12). To test whether relaxation, but not complete 
abrogation of the spindle checkpoint, can increase aneuploidy under normal growth 
conditions, we determined the chromosome counts in metaphase spreads from Bub1 mutant 
and wt MEFs. Seventy-six percent of metaphases from Bub1Δ2-3/Δ2-3 MEFs were aneuploid, 
compared with 9% of wt and 23% of Bub1Δ2-3/+ metaphases (Fig. 3B). Most of the 
aneuploid cells showed gain or loss of only one to two chromosomes. These high levels of 
aneuploidy represent an extreme level of chromosome instability, indicating that Bub1 is 
essential for proper chromosome segregation under unperturbed growth conditions.
Whereas the aneuploidy in Bub1Δ2-3/Δ2-3 MEFs could be due to a relaxed spindle 
checkpoint, Bub1 has also been implicated in proper chromosome congression (i.e., the 
movement of chromosomes to the metaphase plate; refs. 15, 16). To test whether Bub1 
mutant MEFs congress chromosomes properly, synchronized MEFs were treated with the 
proteasome inhibitor MG132 as cells were entering mitosis. Inhibiting the proteasome 
blocks securin and cyclin B degradation, preventing the separation of sister chromatids at 
the metaphase plate and stopping mitosis in metaphase. Defects in chromosome congression 
are detected by an increase in chromosomes that have not aligned at the metaphase plate. 
Consistent with previous RNAi studies (15, 16), MG132-treated Bub1Δ2-3/Δ2-3 MEFs 
showed an increase in chromosome congression defects, with 19.6% of mutant versus 5.7% 
of wt MEFs displaying uncongressed chromsomes (Fig. 3C). This result supports the 
conclusion that Bub1 plays a role in chromosome congression and suggests that defective 
congression may contribute to extreme aneuploidy of Bub1Δ2-3/Δ2-3 MEFs.
Uncongressed chromosomes should trigger a SAC response, delaying anaphase onset until 
congression is complete and kinetochores are under tension. We reasoned that the reduced 
sensitivity of the SAC response in Bub1Δ2-3/Δ2-3 MEFs may allow cells to enter anaphase 
despite the presence of one or more unattached or mono-oriented kinetochores, resulting in 
daughter cells with gain or loss of one to two chromosomes. This model predicts that 
unperturbed cells should have high rates of anaphase lagging chromosomes. Indeed, analysis 
of unperturbed Bub1Δ2-3/Δ2-3 MEFs during anaphase revealed that 47% of Bub1Δ2-3/Δ2-3 
MEFs in anaphase had one or more lagging chromosomes compared with only 9% of wt and 
8% of heterozygotes (Fig. 3D). Taken together, these results suggest that the extreme 
aneuploidy of Bub1Δ2-3/Δ2-3 MEFs is caused by a combination of defects in chromosome 
congression and SAC activation.
Bub1Δ2-3/Δ2-3 MEFs are growth impaired with high rates of senescence
High levels of aneuploidy in BubR1 hypomorphic animals and MEFs correlated with growth 
impairment and high levels of senescence (12). Furthermore, a recent study indicated that 
RNAi knockdown of Bub1 in primary human fibroblasts resulted in increased senescence 
(34). We determined growth and senescence rates in Bub1Δ2-3/Δ2-3 MEFs to assess whether 
similar phenotypes occur in this system. Wt and heterozygous cultures grew at similar rates, 
with expected decreases in cell accumulation at higher passages due to senescence (35), 
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whereas Bub1Δ2-3/Δ2-3 MEFs grew much more slowly (Fig. 4A). To ascertain the cause of 
the growth differences, we assessed levels of apoptosis and senescence. Bub1Δ2-3/Δ2-3 MEFs 
did not show increased apoptosis relative to wt and heterozygous cells, as measured by 
Annexin V staining (data not shown). However, senescence-associated β-galactosidase 
assays revealed that Bub1Δ2-3/Δ2-3 MEFs had a significant increase in senescence compared 
with wt MEFs at passage 3 (9.1% versus 3.1) and passage 5 (15.4% versus 4.4%) examined 
(Fig. 4B and C). The percentage of BrdUrd incorporating cells was also lower in 
Bub1Δ2-3/Δ2-3 MEFs, consistent with the increase in senescent cells (not shown). 
Bub1Δ2-3/Δ2-3 MEFs did not show marked increases in the DNA damage marker 
phosphorylated H2AX (3.1% versus 2.6% in wt MEFs; Fig. 4D), indicating that DNA 
breaks did not contribute significantly to the senescent phenotype. These results indicate that 
the high levels of chromosome missegregation and aneuploidy in Bub1Δ2-3/Δ2-3 cells trigger 
growth impairment via premature senescence.
Impaired Bub1 function predisposes to increased tumorigenesis
Aneuploidy arising from spindle checkpoint impairment or other defects has long been 
hypothesized to contribute to tumor formation. In support of this hypothesis, most 
heterozygous mouse spindle checkpoint mutants generated to date have shown modest 
increases in spontaneous and/or carcinogen-induced tumor formation (11–13, 36). However, 
some evidence suggests that extreme aneuploidy may inhibit tumorigenesis (12, 37). To 
determine if Bub1 impairment contributes to tumor formation, cohorts of (129/
B6)Bub1Δ2-3/Δ2-3 and controls were of ages of 2 years. Approximately, 76% of (129/
B6)Bub1Δ2-3/Δ2-3 mice developed tumors by 23 to 25 months compared with 42% of (129/
B6)Bub1Δ2-3/+ (P < 0.05) and ∼28% of (129/B6)Bub1+/+ animals (P < 0.05; Fig. 5A) As in 
aging wt mice, the majority of (129/B6)Bub1Δ2-3/Δ2-3 tumors were of liver origin and 
occurred at an increased frequency. Importantly, Bub1 mutation also broadened the tumor 
spectrum. Lung tumors appeared in 16% (4 of 25) of (129/B6)Bub1Δ2-3/Δ2-3 mice, whereas 
no lung tumors were found in wt littermate controls (Fig. 5B). Whereas a significant 
increase in spontaneous tumors was not observed in the (129/B6)Bub1Δ2-3/+ cohort, a lung 
tumor and a brain tumor were observed, suggesting a possible change in tumor spectrum. 
These data indicate that Bub1 is a low penetrance tumor suppressor, likely with significant 
quantitative effects based on the genetic modification of phenotypes in distinct genetic 
backgrounds. Together with the results from Bub1Δ2-3/Δ2-3 MEFs, these data indicate that 
chromosome missegregation defects leading to aneuploidy in cells of Bub1 mutant mice 
drive postnatal developmental defects ranging from lethality to tumor formation, depending 
on the associated genetic context.
Discussion
We have probed the functions of the mammalian mitotic regulator Bub1 by generating a 
hypomorphic mutation (Bub1Δ2-3) in mice that lacks part of an NH2 terminal conserved 
domain implicated in spindle checkpoint function in yeast. In addition, the protein is 
expressed at severely diminished levels, yet retains sufficient function to support 
development to birth or adulthood, depending on genetic context. In the C57Bl6/J 
background, homozygous mutant mice die perinatally with a “failure-to-thrive” phenotype, 
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whereas FVB and mixed 129P2/C57Bl6/J backgrounds support survival to late adulthood. 
However, these mice develop a high incidence of cancers compared with wt littermates 
solidifying a role for impaired Bub1 function in tumorigenesis.
Bub1Δ2-3 was characterized as a hypomorphic mutant by demonstrating that compound 
heterozygotes with a gene-trapped allele, Bub1gt8, die by E11.5. Indeed, two contemporary 
reports show that Bub1 null mutants arrest by E7.5 (38, 39), consistent with the early 
embryonic lethality previously described for homozygous null mutants of the SAC genes 
Mad2, BubR1, and Bub3 (7, 8, 10). Based on the proposed Bub1 ATG translation start site, 
the Bub1Δ2-3 mutation was designed to produce a severely truncated protein lacking the 
kinase domain and expected to be nonfunctional. Analyses of the mRNA expressed in 
mutant MEFs indicate that the transcript lacking exons 2 and 3 is expressed at normal levels. 
Immunoprecipitation–Western blot analysis of nocodazole-arrested MEFs identified a 
unique protein in Bub1Δ2-3/+ and Bub1Δ2-3/Δ2-3 MEFs, which is ∼5 kDa smaller than wt 
Bub1 and present at <5% of wt levels. Thus, the mutant Bub1 protein seems to be produced 
by translation from an alternative ATG, the most likely of which would give rise to an NH2 
terminal truncation starting at exon 4, which retains the COOH terminal kinase domain and 
the kinetochore binding domain. The NH2 terminal domain of Bub1 is highly conserved in 
nearly all species, but its function is still largely unknown. In fission yeast, checkpoint 
activity and kinetochore localization were mapped to residues 28-160, whereas mammalian 
Bub1 residues 200-300 were found to be required for SAC function and kinetochore 
localization (6, 32). Because the mutant protein is expressed at such low levels, the current 
studies cannot distinguish whether impaired function results from deletion of a critical NH2 
terminal function, insufficient protein, or both. Future studies will help to distinguish these 
possibilities, as well as determine the reason for the background-dependent phenotypic 
differences found in C57Bl6/J and FVB or mixed background mice. Nonetheless, this 
mutant provides a tool for probing the effects of reduced Bub1 functions in cells and during 
embryonic and adult development.
Bub1 in mitotic checkpoint regulation
MEFs derived from mutant and wt littermate embryos were used to assess the cellular 
phenotypes associated with impaired Bub1 function. A recent RNAi study in cell lines 
questioned a role for mammalian Bub1 in SAC function (15), whereas a distinct study found 
that Bub1 depletion ablated the SAC (16). We show here that, despite undetectable levels of 
Bub1 binding at kinetochores, Mad2 is able to localize at kinetochores in Bub1Δ2-3/Δ2-3 
MEFs, which arrest in mitosis when treated with nocodazole. These surprising results 
indicate that very little Bub1 is required for SAC activity in response to microtubule ablation 
in MEFs. Perera and colleagues (39) recently found that Bub1-null MEFs do not show a 
sustained arrest after treatment with nocodazole, whereas Jeganathan and colleagues (38) 
showed that MEFs with ∼20% of wt Bub1 activity arrest for a shorter duration than wt 
MEFs in nocodazole. The distinct methodologies used (duration of mitotic arrest versus 
mitotic index) make it difficult to directly compare these results to ours and could be 
responsible for the discrepancy. However, this inconsistency raises the possibility of a 
scenario where we have underrepresented the amount of Bub1Δ2-3 protein expressed and 
are primarily observing the effects of the NH2 terminal deletion of the allele. Nevertheless, 
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our results are supported by previous findings with Bub1 small interfering RNA that only 
5% of endogenous levels could support a mitotic arrest with spindle ablation (15, 16). These 
results together are consistent with a model in which a small amount of Bub1 is sufficient to 
arrest cells in response to spindle ablation. This contrasts with the haploinsufficiency of the 
SAC function in MEFs heterozygous for Bub3 or hypomorphic for BubR1, which show very 
little mitotic arrest after nocodazole treatment (9, 12).
In contrast to Mad2, BubR1 kinetochore localization is reduced in Bub1Δ2-3/Δ2-3 MEFs in 
response to nocodazole and is further reduced after Taxol treatment. A similar reduction in 
BubR1 kinetochore localization was recently observed in Bub1-null and hypomorph MEFs, 
providing a strong consensus that Bub1 is critical for BubR1 localization (38, 39). Previous 
kinetochore localization studies suggest that BubR1 is responsive to changes in tension, 
whereas Mad2 binds kinetochores in response to attachment failure (40). The inhibition of 
APC/Cdc20 in response to nocodazole may be due to integration of signals from both 
pathways (as evidenced by strong localization of both BubR1 and Mad2 with nocodazole 
treatment), whereas Taxol may only trigger the BubR1-dependent pathway. While we see a 
reduction in BubR1 kinetochore localization after nocodazole treatment, the presence of 
substantial Mad2 at kinetochores in addition to reduced amounts of BubR1 is apparently 
sufficient for responding to loss of kinetochore-microtubule attachment. Although Bub1 was 
previously shown to be necessary for efficient localization of both Mad2 and BubR1 to 
kinetochores, our data suggest that Bub1 is more critical in the tension-sensitive BubR1 
signaling pathway than in attachment sensing.
We show here that Bub1Δ2-3/Δ2-3 MEFs rapidly develop a high frequency of aneuploidy that 
is likely explained by a weakened SAC response. Nocodazole-treated and Taxol-treated 
Bub1Δ2-3/Δ2-3 MEFs have a reduced mitotic index relative to wt cells; yet, these assays are 
relatively crude and may not accurately measure weakened signaling capacity. A more 
sensitive test of SAC function comes when most chromosomes achieve bipolar attachment 
and tension, as the remaining signal from even a single unattached kinetochore must be 
sufficient to block anaphase onset until attachment and tension are achieved (41, 42). Under 
these conditions, insufficiency of SAC components may impair the SAC enough to allow 
anaphase onset, resulting in lagging chromosome(s). The high frequency of Bub1Δ2-3/Δ2-3 
cells with lagging chromosomes, coupled with the fact that only one or two such 
chromosomes are observed in most cells, suggests that chromosome missegregation in 
Bub1Δ2-3/Δ2-3 cells is triggered by a defect in sensing minor, rather than catastrophic, mitotic 
aberrations. Bub1 has also been reported to play a role in chromosome congression and 
regulation of sister chromatid cohesion (15, 16, 19, 20). We observed an increase in 
chromosome congression errors in Bub1Δ2-3/Δ2-3 MEFs, suggesting that this mechanism may 
contribute to the mitotic errors in these cells. However, the percentage of cells with obvious 
congression errors was low relative to the percentage with lagging chromosomes, suggesting 
that congression errors are unlikely to account for the full extent of missegregation 
observed. Moreover, noncongressed chromosomes should invoke a SAC arrest under normal 
conditions. Therefore, we argue that the mitotic defects in Bub1Δ2-3/Δ2-3 MEFs are a 
consequence of impairment in both chromosome congression and SAC signaling.
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A large body of evidence indicates that cellular senescence suppresses cellular proliferation 
in response to DNA damage and/or oncogene activation. Here, we show that Bub1Δ2-3/Δ2-3 
MEFs are significantly growth impaired and produce high levels of premature senescence. 
This effect was less severe in Bub1Δ2-3/+ MEFs, which also displayed lower levels of 
aneuploidy. Thus, a major consequence of impaired Bub1 function and resulting 
chromosome segregation errors seems to be permanent cell cycle arrest. Increased 
senescence was also observed in BubR1 hypomorph mice (12), which also display high rates 
of aneuploidy. Furthermore, aneuploid yeasts were recently shown to display impaired 
growth and metabolic changes accompanied by evidence of protein degradation and folding 
distress (43). Thus, it is possible that the increased metabolic demand of extra chromosomes 
taxes cellular machinery, causing a stress response that triggers senescence. Aneuploidy may 
also trigger stress responses by causing imbalances in signaling pathways.
Bub1 and tumor suppression
Aneuploidy has long been associated with cancers, raising the hypothesis that spindle 
checkpoint impairment may predispose to tumorigenesis (44–46). Indeed, the presence of 
Bub1 mutations in human colon cancer cell lines (21) and murine lymphomas (22) fueled 
this hypothesis. Here, we show a causal relationship between impaired Bub1 function and 
predisposition to cancer. When analyzed in a background permissive to survival, impaired 
Bub1 function predisposed to a higher frequency and expanded spectrum of tumors relative 
to wt littermates. Tumors arose in aging mice, indicative of a low penetrance effect, 
consistent with the notion that noncatastrophic rates of aneuploidy can produce tumorigenic 
chromosomal imbalances. Mice heterozygous for a null mutation of other SAC genes also 
resulted in increased tumor incidence, either spontaneously [Mad1 (36), Mad2 (11), Cenp-E 
(37)] or after carcinogen treatment [BubR1 (13) and Bub3 (9)]. The recent work of 
Jeganathan and colleagues (38) showed an increasing tumor incidence with progressive loss 
of Bub1, reaching 55% in mice with ∼20% of endogenous Bub1 levels. The higher tumor 
incidence (76%) in our model correlates with the further reduction in Bub1 levels to <5% 
and the corresponding increase in mitotic abnormalities. A severe hypomorphic allele of 
BubR1 caused only a modest increase in tumorigenesis; however, animals aged prematurely, 
potentially confounding the quantitative assessment of tumor incidence (12). CENPE 
haploinsufficiency, which also causes severe aneuploidy, was recently shown to have either 
protective or tumorigenic effects, depending on the genetic and environmental context (37). 
Thus, the influence of mitotic infidelity on tumor formation seems to be dependent on the 
cellular and genetic context and likely reflects a quantitative trait. The level of mitotic 
disruption may be critical for tumor formation, with high levels of chromosome 
missegregation incompatible with cell survival or activating tumor suppression pathways, 
such as senescence. Future study of the hypomorphic Bub1Δ2-3 mutation in the context of an 
allelic series with other available Bub1 mutations, in addition to alterations in senescence 
pathway factors, such as p53, should provide valuable insight into to the mechanistic 
relationship between mitotic aberration, chromosome instability, and cancer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Bub1 gene disruption. A, the BubΔ2-3 allele removes a portion of the NH2 terminal 
conserved domain. Top, schematic of Bub1 protein domains and corresponding exons; 
bottom, possible protein products produced from the BubΔ2-3 allele. B, Western blot analysis 
of endogenous Bub1 protein in MEFs of indicated genotypes. No protein is detected from 
Bub1Δ2-3/Δ2-3 cells. GapDH was used as a loading control. C, titration of lysate from 
Bub1+/+ MEFs indicating that the Bub1 antibody detects 5% of endogenous levels. D, 
immunoprecipitation–Western blot. Arrow indicates a novel polypeptide detected in lysates 
from cells harboring the Bub1Δ2-3 allele.
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Bub1 and BubR1 are reduced at kinetochores in Bub1Δ2-3/Δ2-3 MEFs. A, left, quantitation of 
Bub1 levels at kinetochores normalized to ACA (centromere marker); right, representative 
Bub1, ACA, and merged images from wt and Bub1 mutant MEFs. B, representative images 
illustrating staining level classifications used in quantitations for C-D. C, Mad2 kinetochore 
localization after treatment with nocodazole (left) and Taxol (right). Bars, percentage of 
cells of each class depicted in B. D, BubR1 kinetochore localization after treatment with 
nocodazole (left) and Taxol (right). n = 50 cells each from three individual experiments for 
C and D.
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Bub1Δ2-3/Δ2-3 MEFs have reduced spindle checkpoint activity and increased mitotic 
abnormalities. A, accumulation of mitotic (phosphorylated histone H3-positive) cells after 
nocodazole treatment (left) and Taxol treatment (right). B, incidence of aneuploid cells in P5 
MEFs. C, quantitation of uncongressed chromsomes after 3 h of MG132 treatment with 
representative image of a metaphase nucleus with an uncongressed chromosome. D, 
quantitation of anaphase lagging chromosomes with representative image. Graphs in A, C, 
and D represent mean and SE of three independent experiments for each genotype with at 
least 10,000 cells analyzed per genotype per experiment in A and at least 50 cells per 
genotype per experiment for C and D. *, P < 0.05.
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Bub1Δ2-3/Δ2-3 MEFcultures have reduced growth and increased senescence. A, total cell 
numbers accumulated at indicated passages. Cells (500,000) were plated at each passage 
(lower markers) and total cells counted upon passage 2 d later (top markers). B, 
representative acidic β-galactosidase staining (blue) of a Bub1Δ2-3/Δ2-3 culture. C, senescent 
cells as a percentage of total cells at passages 3, 5, and 7. n = 3 independent experiments per 
genotype. D, Bub1Δ2-3/Δ2-3 MEFs do not show increased DNA damage. Percentage of cells 
positive for phosphorylated H2AX immunostaining. Teal bars indicate duplicate control 
samples treated with doxorubicin to induce DNA damage. *, P < 0.05. Bars, SE.
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Tumor incidence and spectrum is increased with Bub1 mutation. A, tumor incidence in 
Bub1Δ2-3/Δ2-3 mice and controls. B, tumor spectrum.
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Table 1
Viability of Bub1 mutant mice
Genotype Background Live births E18.5 E14.5
Bub1Δ2-3/+ × Bub1Δ2-3/+
 +/+ B6 68 26 17
 Δ2-3/+ 109 39 34
 Δ2-3/∆2-3 18* (2)† 22 18
 +/+ FVB 33
 Δ2-3/+ 76
 Δ2-3/Δ2-3 35
 +/+ B6/129 162 15
 Δ2-3/+ 353 23
 Δ2-3/Δ2-3 96 14
Bub1Δ2-3/+ × Bub1gt8/+
 +/+ B6/129 40 10
 Δ2-3/+ 30 27
 gt8/+ 21 10




Two mice survived to weaning at 21 d.
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